183 related articles for article (PubMed ID: 29803870)
1. The role of depressive symptoms in treatment of adolescent cannabis use disorder with N-Acetylcysteine.
Tomko RL; Gilmore AK; Gray KM
Addict Behav; 2018 Oct; 85():26-30. PubMed ID: 29803870
[TBL] [Abstract][Full Text] [Related]
2. Depressive symptoms and cannabis use in a placebo-controlled trial of N-Acetylcysteine for adult cannabis use disorder.
Tomko RL; Baker NL; Hood CO; Gilmore AK; McClure EA; Squeglia LM; McRae-Clark AL; Sonne SC; Gray KM
Psychopharmacology (Berl); 2020 Feb; 237(2):479-490. PubMed ID: 31712969
[TBL] [Abstract][Full Text] [Related]
3. A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults.
Gray KM; Sonne SC; McClure EA; Ghitza UE; Matthews AG; McRae-Clark AL; Carroll KM; Potter JS; Wiest K; Mooney LJ; Hasson A; Walsh SL; Lofwall MR; Babalonis S; Lindblad RW; Sparenborg S; Wahle A; King JS; Baker NL; Tomko RL; Haynes LF; Vandrey RG; Levin FR
Drug Alcohol Depend; 2017 Aug; 177():249-257. PubMed ID: 28623823
[TBL] [Abstract][Full Text] [Related]
4. Low Pretreatment Impulsivity and High Medication Adherence Increase the Odds of Abstinence in a Trial of N-Acetylcysteine in Adolescents with Cannabis Use Disorder.
Bentzley JP; Tomko RL; Gray KM
J Subst Abuse Treat; 2016 Apr; 63():72-7. PubMed ID: 26827257
[TBL] [Abstract][Full Text] [Related]
5. Alcohol use during a trial of N-acetylcysteine for adolescent marijuana cessation.
Squeglia LM; Baker NL; McClure EA; Tomko RL; Adisetiyo V; Gray KM
Addict Behav; 2016 Dec; 63():172-7. PubMed ID: 27521979
[TBL] [Abstract][Full Text] [Related]
6. A double-blind randomized controlled trial of N-acetylcysteine in cannabis-dependent adolescents.
Gray KM; Carpenter MJ; Baker NL; DeSantis SM; Kryway E; Hartwell KJ; McRae-Clark AL; Brady KT
Am J Psychiatry; 2012 Aug; 169(8):805-12. PubMed ID: 22706327
[TBL] [Abstract][Full Text] [Related]
7. The effect of N-acetylcysteine on alcohol use during a cannabis cessation trial.
Squeglia LM; Tomko RL; Baker NL; McClure EA; Book GA; Gray KM
Drug Alcohol Depend; 2018 Apr; 185():17-22. PubMed ID: 29413434
[TBL] [Abstract][Full Text] [Related]
8. Achieving cannabis cessation -- evaluating N-acetylcysteine treatment (ACCENT): design and implementation of a multi-site, randomized controlled study in the National Institute on Drug Abuse Clinical Trials Network.
McClure EA; Sonne SC; Winhusen T; Carroll KM; Ghitza UE; McRae-Clark AL; Matthews AG; Sharma G; Van Veldhuisen P; Vandrey RG; Levin FR; Weiss RD; Lindblad R; Allen C; Mooney LJ; Haynes L; Brigham GS; Sparenborg S; Hasson AL; Gray KM
Contemp Clin Trials; 2014 Nov; 39(2):211-23. PubMed ID: 25179587
[TBL] [Abstract][Full Text] [Related]
9. Cigarette smoking during an N-acetylcysteine-assisted cannabis cessation trial in adolescents.
McClure EA; Baker NL; Gray KM
Am J Drug Alcohol Abuse; 2014 Jul; 40(4):285-91. PubMed ID: 24720376
[TBL] [Abstract][Full Text] [Related]
10. Double-blind fluoxetine trial in comorbid MDD-CUD youth and young adults.
Cornelius JR; Bukstein OG; Douaihy AB; Clark DB; Chung TA; Daley DC; Wood DS; Brown SJ
Drug Alcohol Depend; 2010 Nov; 112(1-2):39-45. PubMed ID: 20576364
[TBL] [Abstract][Full Text] [Related]
11. N-Acetylcysteine in the Treatment of Pediatric Tourette Syndrome: Randomized, Double-Blind, Placebo-Controlled Add-On Trial.
Bloch MH; Panza KE; Yaffa A; Alvarenga PG; Jakubovski E; Mulqueen JM; Landeros-Weisenberger A; Leckman JF
J Child Adolesc Psychopharmacol; 2016 May; 26(4):327-34. PubMed ID: 27027204
[TBL] [Abstract][Full Text] [Related]
12. Tobacco use during cannabis cessation: Use patterns and impact on abstinence in a National Drug Abuse Treatment Clinical Trials Network study.
McClure EA; Baker NL; Sonne SC; Ghitza UE; Tomko RL; Montgomery L; Babalonis S; Terry GE; Gray KM
Drug Alcohol Depend; 2018 Nov; 192():59-66. PubMed ID: 30218864
[TBL] [Abstract][Full Text] [Related]
13. Cognitive performance in a placebo-controlled pharmacotherapy trial for youth with marijuana dependence.
Roten A; Baker NL; Gray KM
Addict Behav; 2015 Jun; 45():119-23. PubMed ID: 25661990
[TBL] [Abstract][Full Text] [Related]
14. Temporal dynamics of the relationship between change in depressive symptoms and cannabis use in adolescents receiving psychosocial treatment for cannabis use disorder.
Arias AJ; Hammond CJ; Burleson JA; Kaminer Y; Feinn R; Curry JF; Dennis ML
J Subst Abuse Treat; 2020 Oct; 117():108087. PubMed ID: 32811625
[TBL] [Abstract][Full Text] [Related]
15. N-acetylcysteine for smoking cessation among dual users of tobacco and cannabis: Protocol and rationale for a randomized controlled trial.
Herbst ED; Pennington DL; Borsari B; Manuel J; Yalch M; Alcid E; Martinez Rivas M; Delacruz J; Rossi N; Garcia B; Wong N; Batki SL
Contemp Clin Trials; 2023 Aug; 131():107250. PubMed ID: 37271412
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological Treatment of Cannabis-Related Disorders: A Narrative Review.
Gorelick DA
Curr Pharm Des; 2016; 22(42):6409-6419. PubMed ID: 27549375
[TBL] [Abstract][Full Text] [Related]
17. The efficacy of adjunctive N-acetylcysteine in major depressive disorder: a double-blind, randomized, placebo-controlled trial.
Berk M; Dean OM; Cotton SM; Jeavons S; Tanious M; Kohlmann K; Hewitt K; Moss K; Allwang C; Schapkaitz I; Robbins J; Cobb H; Ng F; Dodd S; Bush AI; Malhi GS
J Clin Psychiatry; 2014 Jun; 75(6):628-36. PubMed ID: 25004186
[TBL] [Abstract][Full Text] [Related]
18. Results from a randomized, double-blind, placebo-controlled, crossover, multimodal-MRI pilot study of gabapentin for co-occurring bipolar and cannabis use disorders.
Prisciandaro JJ; Mellick W; Squeglia LM; Hix S; Arnold L; Tolliver BK
Addict Biol; 2022 Jan; 27(1):e13085. PubMed ID: 34390300
[TBL] [Abstract][Full Text] [Related]
19. Who responds to a multi-component treatment for cannabis use disorder? Using multivariable and machine learning models to classify treatment responders and non-responders.
Tomko RL; Wolf BJ; McClure EA; Carpenter MJ; Magruder KM; Squeglia LM; Gray KM
Addiction; 2023 Oct; 118(10):1965-1974. PubMed ID: 37132085
[TBL] [Abstract][Full Text] [Related]
20. Metabolite profiles in the anterior cingulate cortex of depressed patients differentiate those taking N-acetyl-cysteine versus placebo.
Das P; Tanious M; Fritz K; Dodd S; Dean OM; Berk M; Malhi GS
Aust N Z J Psychiatry; 2013 Apr; 47(4):347-54. PubMed ID: 23341476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
